Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

KLF4 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

KLF4 overexpression	Breast Cancer	KLF4 overexpression	Breast Cancer	tamoxifen Sensitive: C3 – Early Trials tamoxifen Sensitive : C3	tamoxifen Sensitive: C3 – Early Trials tamoxifen Sensitive : C3
KLF4 overexpression	Nasopharyngeal Carcinoma	KLF4 overexpression	Nasopharyngeal Carcinoma	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3
KLF4 overexpression	Head and Neck Cancer	KLF4 overexpression	Head and Neck Cancer	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3
KLF4 overexpression	Colon Cancer	KLF4 overexpression	Colon Cancer	cisplatin Sensitive: D – Preclinical cisplatin Sensitive : D	cisplatin Sensitive: D – Preclinical cisplatin Sensitive : D